The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Nannapaneni
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanjay Nannapaneni, a member of the Natco Pharma promoter group, sold 1,00,000 equity shares (face value Rs. 2 each) in the open market on September 29-30, 2025. The sale represents 0.05% of the company's total equity share capital (17,91,09,870 shares). His holding dropped from 3,26,910 shares (0.18%) to 2,26,910 shares (0.13%) after the transaction. The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations, 2011. This is a routine small-quantity sale by a promoter group member.
The sale size is very small (0.05% of capital) and unlikely to materially affect the stock price or shareholder value. Minor promoter selling is typically viewed as a slightly cautious signal, but the quantum here is negligible.